Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ViiV Healthcare

Division of GlaxoSmithKline PLC
www.viivhealthcare.com

Latest From ViiV Healthcare

GSK Q2 Preview: Focus On PARP And HIV Pill

Analysts are waiting to see how the drugs giant intends to drive growth for new products, with a particular interest in the prospects for the PARP inhibitor Zejula and the single-pill, two-drug HIV therapy Dovato.

Sales & Earnings Cancer

WHO’s Expanded Essential Drugs List Includes High-Priced Anticancers & Immunomodulators

The World Health Organization has published its latest list of essential medicines, with a number of expensive drugs for cancers and autoimmune disorders figuring for the first time. The organization says that all patients should have access to life-saving medicines regardless of their ability to pay, but the pharmaceutical industry says this should be done with caution to avoid undermining innovation.

International Market Access

A Switch To ViiV's Two-Drug Dovato Keeps HIV Suppressed

Top-line results from the Phase III TANGO study suggests that switching to ViiV’s two-drug Dovato from a three-drug regimen does not affect the efficacy of treatment.

ViiV's Dovato Could Challenge Status Quo In Naive EU HIV Patients

The approval of ViiV’s new once-daily, two-drug single-pill for HIV/AIDS could lead to a tough battle in Europe with established therapies.

  

Approvals Infectious Diseases
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • GSK Pfizer HIV
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • GlaxoSmithKline PLC
  • Senior Management
  • Jerome Andries, CFO
    John Pottage, MD, CSO & CMO
    Gregory Reinaud, Head, Global Commercial Strategy
  • Contact Info
  • ViiV Healthcare
    Phone: (44) (0)20 8380 6200
    980 Great West Rd.
    Brentford, TW8 9GS
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register